Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 8 14 SULFITE FREE IN DEXTROSE 14 IN PLASTIC CONTAINER versus TRAVASOL 4 25 IN DEXTROSE 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 8 14 SULFITE FREE IN DEXTROSE 14 IN PLASTIC CONTAINER versus TRAVASOL 4 25 IN DEXTROSE 25 IN PLASTIC CONTAINER.
CLINIMIX 8/14 SULFITE FREE IN DEXTROSE 14% IN PLASTIC CONTAINER vs TRAVASOL 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Provides essential amino acids and dextrose for parenteral nutrition, supporting protein synthesis and energy metabolism.
TRAVASOL 4.25% IN DEXTROSE 25% provides crystalline amino acids and dextrose for parenteral nutrition. Amino acids serve as substrates for protein synthesis, while dextrose provides a carbohydrate source for energy. The formulation supplies essential and nonessential amino acids to maintain nitrogen balance and support tissue repair and growth.
Intravenous infusion. Dose individualized based on metabolic requirements, energy expenditure, and clinical status. Typical adult dose: 500 mL to 1000 mL per day, providing 8% amino acids and 14% dextrose, infused at a rate not exceeding 0.1 g/kg/hr of amino acids and 0.5 g/kg/hr of dextrose.
Intravenous infusion; usual adult dose provides 0.5-2.0 g amino acids/kg/day, with dextrose providing 2-5 mg/kg/min; rate adjusted according to metabolic and fluid needs; typically infused over 24 hours via central line.
None Documented
None Documented
Not applicable as individual components (amino acids, dextrose, electrolytes) are not eliminated via first-order kinetics; amino acids have a plasma half-life of minutes to hours depending on metabolic demand and renal function.
Not applicable as TRAVASOL 4.25% IN DEXTROSE 25% is a nutrient solution, not a drug with a defined elimination half-life.
Renal excretion of urea and other nitrogenous waste products; no biliary or fecal elimination of nutrients.
The amino acids and dextrose are completely metabolized; no significant renal or biliary excretion of intact product.
Category C
Category C
Parenteral Nutrition Solution
Parenteral Nutrition Solution